Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

854 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Decreased serum levels of the inflammaging marker miR-146a are associated with clinical non-response to tocilizumab in COVID-19 patients.
Sabbatinelli J, Giuliani A, Matacchione G, Latini S, Laprovitera N, Pomponio G, Ferrarini A, Svegliati Baroni S, Pavani M, Moretti M, Gabrielli A, Procopio AD, Ferracin M, Bonafè M, Olivieri F. Sabbatinelli J, et al. Among authors: gabrielli a. Mech Ageing Dev. 2021 Jan;193:111413. doi: 10.1016/j.mad.2020.111413. Epub 2020 Dec 8. Mech Ageing Dev. 2021. PMID: 33307107 Free PMC article. Clinical Trial.
Circulating miR-320b and miR-483-5p levels are associated with COVID-19 in-hospital mortality.
Giuliani A, Matacchione G, Ramini D, Di Rosa M, Bonfigli AR, Sabbatinelli J, Monsurrò V, Recchioni R, Marcheselli F, Marchegiani F, Piacenza F, Cardelli M, Galeazzi R, Pomponio G, Ferrarini A, Gabrielli A, Svegliati Baroni S, Moretti M, Sarzani R, Giordano P, Cherubini A, Corsonello A, Antonicelli R, Procopio AD, Ferracin M, Bonafè M, Lattanzio F, Olivieri F. Giuliani A, et al. Among authors: gabrielli a. Mech Ageing Dev. 2022 Mar;202:111636. doi: 10.1016/j.mad.2022.111636. Epub 2022 Feb 2. Mech Ageing Dev. 2022. PMID: 35122770 Free PMC article.
Tocilizumab in COVID-19 interstitial pneumonia.
Pomponio G, Ferrarini A, Bonifazi M, Moretti M, Salvi A, Giacometti A, Tavio M, Titolo G, Morbidoni L, Frausini G, Onesta M, Amico D, Rocchi MLB, Menzo S, Zuccatosta L, Mei F, Menditto V, Svegliati S, Donati A, D'Errico MM, Pavani M, Gabrielli A. Pomponio G, et al. Among authors: gabrielli a. J Intern Med. 2021 May;289(5):738-746. doi: 10.1111/joim.13231. Epub 2021 Jan 29. J Intern Med. 2021. PMID: 33511686 Free PMC article.
Agonistic antibodies in systemic sclerosis.
Moroncini G, Svegliati Baroni S, Gabrielli A. Moroncini G, et al. Among authors: gabrielli a. Immunol Lett. 2018 Mar;195:83-87. doi: 10.1016/j.imlet.2017.10.007. Epub 2017 Oct 13. Immunol Lett. 2018. PMID: 29032187 Review.
Sustained clinical response after single course of rituximab as first-line monotherapy in adult-onset asthma and periocular xanthogranulomas syndrome associated with IgG4-related disease: A case report.
Pomponio G, Olivari D, Mattioli M, Angeletti A, Rossetti G, Goteri G, Gabrielli A. Pomponio G, et al. Among authors: gabrielli a. Medicine (Baltimore). 2018 Jun;97(26):e11143. doi: 10.1097/MD.0000000000011143. Medicine (Baltimore). 2018. PMID: 29952960 Free PMC article.
Putative functional pathogenic autoantibodies in systemic sclerosis.
Benfaremo D, Svegliati Baroni S, Manfredi L, Moroncini G, Gabrielli A. Benfaremo D, et al. Among authors: gabrielli a. Eur J Rheumatol. 2020 Oct;7(Suppl 3):S181-S186. doi: 10.5152/eurjrheum.2020.19131. Epub 2020 Oct 1. Eur J Rheumatol. 2020. PMID: 33164733 Free PMC article. Review.
854 results